Crh Plc (CRH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRH SEC filings page.
Crh Plc (CRH) reported $38.6B in revenue over the twelve months to Jun 30, 2026, up 6.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
CRH converts sustained revenue growth into wider operating margins while funding a more asset-heavy expansion with rising leverage.
Operating efficiency improved across the cycle: between FY2022 and FY2025, operating margin widened by 2.9 percentage points while free-cash-flow margin finished above its FY2024 level. In FY2025, operating cash flow of$5.6B exceeded net income of$3.8B , showing that reported earnings were backed by cash even as reinvestment remained substantial.
Margin expansion outpaced overhead growth: gross margin and operating margin both widened through FY2025 despite SG&A rising to
Debt-to-equity moved from 0.5x in FY2024 to 0.7x in FY2025, indicating that the balance sheet became more leveraged as the business expanded. Total assets increased by
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Crh Plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Crh Plc has an operating margin of 14.5%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is up from 13.9% the prior year.
Crh Plc's revenue grew 5.3% year-over-year to $37.4B, a solid pace of expansion. This earns a growth score of 43/100.
Crh Plc has a moderate D/E ratio of 0.69. This balance of debt and equity financing earns a leverage score of 36/100.
Crh Plc's current ratio of 1.74 indicates adequate short-term liquidity, earning a score of 51/100. The company can meet its near-term obligations, though with limited headroom.
Crh Plc has a free cash flow margin of 7.8%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.
Crh Plc earns a strong 15.6% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is down from 16.2% the prior year.
Crh Plc scores 2.78, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Crh Plc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Crh Plc generates $1.50 in operating cash flow ($5.6B OCF vs $3.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Crh Plc earns $6.72 in operating income for every $1 of interest expense ($5.4B vs $810.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Crh Plc generated $10.8B in revenue in Q2 2026. This represents an increase of 5.6% from the same quarter a year earlier. Against the prior quarter it is up 46.2%.
Crh Plc's EBITDA was $2.6B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.7% from the same quarter a year earlier. Against the prior quarter it is up 388.3%.
Crh Plc reported $1.5B in net income in Q2 2026. This represents an increase of 12.7% from the same quarter a year earlier. Against the prior quarter it is up 944.3%.
Crh Plc earned $2.21 per diluted share (EPS) in Q2 2026. This represents an increase of 13.9% from the same quarter a year earlier. Against the prior quarter it is up 918.5%.
Cash & Balance Sheet
Crh Plc generated $490.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 32.2% from the same quarter a year earlier. Against the prior quarter it is up 140.3%.
Crh Plc held $3.0B in cash against $15.4B in long-term debt as of Q2 2026.
Crh Plc paid $0.39 per share in dividends in Q2 2026. This represents an increase of 5.4% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Crh Plc's gross margin was 39.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.1 percentage points.
Crh Plc's operating margin was 19.3% in Q2 2026, reflecting core business profitability. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 19.8 percentage points.
Crh Plc's net profit margin was 13.8% in Q2 2026, showing the share of revenue converted to profit. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.2 percentage points.
Crh Plc's ROE was 6.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.9 percentage points.
Capital Allocation
Crh Plc spent $275.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 17.7% from the same quarter a year earlier. Against the prior quarter it is down 17.2%.
Crh Plc invested $639.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 2.4% from the same quarter a year earlier. Against the prior quarter it is up 6.3%.
Not reported for Q2 2026.
CRH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B+5.6% | $7.4B+9.1% | $9.4B+6.2% | $11.1B+5.3% | $10.2B+5.7% | $6.8B+3.4% | $8.9B+2.1% | $10.5B+3.8% |
| Cost of Revenue | $6.5B+4.9% | $5.3B+8.3% | $6.1B+6.1% | $6.8B+4.7% | $6.2B+3.4% | $4.9B+4.1% | $5.7B-0.4% | $6.5B+1.4% |
| Gross Profit | $4.3B+6.7% | $2.0B+11.3% | $3.4B+6.2% | $4.3B+6.2% | $4.0B+9.6% | $1.8B+1.7% | $3.2B+7.1% | $4.1B+7.9% |
| SG&A Expenses | $2.3B+6.9% | $2.1B+12.2% | $2.0B+3.1% | $2.3B+7.1% | $2.1B+8.8% | $1.8B+2.6% | $1.9B+5.1% | $2.2B+9.7% |
| Operating Income | $2.1B+7.4% | -$38.0M-311.1% | $1.4B+27.4% | $2.1B+6.0% | $1.9B+5.8% | $18.0M-35.7% | $1.1B+41.0% | $2.0B+9.8% |
| EBITDA | $2.6B+6.7% | $538.0M+8.7% | N/A | N/A | $2.5B+9.3% | $495.0M+16.5% | $1.6B+31.3% | $2.4B+11.0% |
| Interest Expense | $220.0M+10.0% | $203.0M+12.2% | $220.0M+37.5% | $209.0M+27.4% | $200.0M+29.0% | $181.0M+36.1% | $160.0M+75.8% | $164.0M+25.2% |
| Income Tax | $661.0M+55.5% | -$55.0M+5.2% | $246.0M+72.0% | $428.0M-19.4% | $425.0M-1.2% | -$58.0M-205.3% | $143.0M-0.7% | $531.0M+27.6% |
| Net Income | $1.5B+12.7% | -$176.0M-87.2% | $1.0B+45.8% | $1.5B+9.2% | $1.3B+1.7% | -$94.0M-181.0% | $703.0M+0.3% | $1.4B+5.4% |
| EPS (Basic) | $2.22+13.8% | -$0.27-80.0% | $1.52+47.6% | $2.23+12.1% | $1.95+3.2% | -$0.15-193.8% | $1.03+3.0% | $1.99+9.9% |
| EPS (Diluted) | $2.21+13.9% | -$0.27-80.0% | $1.52+49.0% | $2.21+12.2% | $1.94+3.2% | -$0.15-193.8% | $1.02+3.0% | $1.97+9.4% |
| Diluted Shares (Avg) | 669M-1.3% | 669M-1.2% | N/A | 676M-1.5% | 678M-1.6% | 677M-2.4% | N/A | 686M-5.1% |
Not reported in any period shown, so not listed: R&D Expenses.
CRH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.6B+8.5% | $58.2B+12.0% | $58.3B+15.2% | $58.5B+14.3% | $54.0B+12.2% | $51.9B+12.1% | $50.6B+6.6% | $51.2B+7.5% |
| Current Assets | $15.8B+4.0% | $16.2B+14.0% | $15.3B+8.3% | $16.9B+13.6% | $15.2B+0.3% | $14.2B+3.9% | $14.1B-16.6% | $14.8B-9.0% |
| Cash & Equivalents | $3.0B+5.2% | $3.2B-3.3% | $4.1B+10.1% | $4.2B+41.0% | $2.9B-6.2% | $3.4B+1.3% | $3.7B-41.3% | $3.0B-48.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $5.1B+1.0% | $5.1B+2.0% | $5.3B+10.4% | $5.0B+8.1% | $5.1B+11.9% | $5.0B+7.4% | $4.8B+10.8% | $4.6B+10.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $13.2B+12.7% | $12.6B+9.7% | $13.1B+18.4% | $12.7B+16.2% | $11.7B+13.9% | $11.5B+13.3% | $11.1B+20.8% | $10.9B+14.3% |
| Total Liabilities | $33.0B+8.8% | $33.6B+13.7% | $32.9B+18.3% | $33.9B+20.8% | $30.4B+13.9% | $29.6B+15.5% | $27.8B+7.4% | $28.1B+12.3% |
| Current Liabilities | $10.0B+14.9% | $10.2B+17.2% | $8.8B-15.0% | $11.6B+8.7% | $8.7B-17.7% | $8.7B-12.9% | $10.3B+2.8% | $10.7B+16.1% |
| Non-Current Liabilities | $23.0B+6.3% | $23.4B+12.3% | $24.1B+38.0% | $22.3B+28.3% | $21.7B+34.5% | $20.9B+33.7% | $17.5B+10.3% | $17.4B+10.1% |
| Long-Term Debt | $15.4B+5.2% | $16.1B+13.1% | $16.5B+50.2% | $14.7B+38.1% | $14.6B+47.9% | $14.2B+46.8% | $11.0B+12.2% | $10.7B+11.9% |
| Total Equity | $24.0B+7.6% | $23.1B+9.2% | $24.0B+11.1% | $23.3B+6.6% | $22.3B+7.8% | $21.1B+5.5% | $21.6B+3.6% | $21.9B+0.5% |
| Retained Earnings | $25.7B+6.8% | $24.8B+6.1% | $25.6B+6.5% | $25.1B+5.2% | $24.1B+4.7% | $23.4B+4.6% | $24.0B+4.9% | $23.8B-0.4% |
Not reported in any period shown, so not listed: Accounts Receivable.
CRH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B-18.1% | -$616.0M+6.5% | $2.9B+6.8% | $2.0B+34.0% | $1.4B-7.2% | -$659.0M+7.4% | $2.7B+12.7% | $1.5B-8.9% |
| Depreciation & Amortization | $548.0M+3.8% | $576.0M+20.8% | N/A | N/A | $528.0M+24.5% | $477.0M+20.2% | $510.0M+14.3% | $467.0M+16.2% |
| Stock-Based Compensation | N/A | $29.0M-9.4% | N/A | N/A | N/A | $32.0M+6.7% | N/A | N/A |
| Capital Expenditures | $639.0M-2.4% | $601.0M-6.8% | $821.0M-12.9% | $592.0M+17.2% | $655.0M+5.0% | $645.0M+27.5% | $943.0M+46.9% | $505.0M+25.0% |
| Free Cash Flow | $490.0M-32.2% | -$1.2B+6.7% | $2.1B+17.2% | $1.4B+42.6% | $723.0M-16.0% | -$1.3B-7.1% | $1.8B+0.3% | $981.0M-20.0% |
| Investing Cash Flow | $134.0M+116.1% | -$722.0M+25.1% | -$1.3B+29.0% | -$2.9B-62.8% | -$831.0M-59.5% | -$964.0M+54.0% | -$1.9B-184.9% | -$1.8B-135.6% |
| Financing Cash Flow | -$1.5B-31.9% | $572.0M-49.9% | -$1.7B-4002.4% | $2.3B+470.6% | -$1.2B-240.1% | $1.1B+748.3% | -$42.0M+96.7% | -$629.0M-196.9% |
| Share Buybacks | $275.0M-17.7% | $332.0M+7.1% | $251.0M-2.7% | $286.0M-9.8% | $334.0M-4.0% | $310.0M-44.5% | $258.0M-75.1% | $317.0M-70.4% |
Not reported in any period shown, so not listed: Dividends Paid.
CRH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.8%+0.4pp | 27.8%+0.6pp | 35.6%0.0pp | 38.9%+0.3pp | 39.5%+1.4pp | 27.2%-0.5pp | 35.6%+1.7pp | 38.6%+1.5pp |
| Operating Margin | 19.3%+0.3pp | -0.5%-0.8pp | 14.9%+2.5pp | 18.8%+0.1pp | 19.0%0.0pp | 0.3%-0.2pp | 12.4%+3.4pp | 18.7%+1.0pp |
| Net Margin | 13.8%+0.9pp | -2.4%-1.0pp | 10.9%+3.0pp | 13.6%+0.5pp | 12.9%-0.5pp | -1.4%-3.2pp | 7.9%-0.1pp | 13.1%+0.2pp |
| Return on Equity | 6.2%+0.3pp | -0.8%-0.3pp | 4.3%+1.0pp | 6.5%+0.2pp | 5.9%-0.4pp | -0.4%-1.0pp | 3.3%-0.1pp | 6.3%+0.3pp |
| Return on Assets | 2.5%+0.1pp | -0.3%-0.1pp | 1.8%+0.4pp | 2.6%-0.1pp | 2.4%-0.3pp | -0.2%-0.4pp | 1.4%-0.1pp | 2.7%-0.1pp |
| Current Ratio | 1.58-0.2x | 1.590.0x | 1.74+0.4x | 1.45+0.1x | 1.74+0.3x | 1.63+0.3x | 1.37-0.3x | 1.39-0.4x |
| Debt-to-Equity | 0.640.0x | 0.700.0x | 0.69+0.2x | 0.63+0.1x | 0.66+0.2x | 0.67+0.2x | 0.510.0x | 0.490.0x |
| Asset Turnover | 0.180.0x | 0.130.0x | 0.160.0x | 0.190.0x | 0.190.0x | 0.130.0x | 0.180.0x | 0.210.0x |
| FCF Margin | 4.5%-2.5pp | -16.5%+2.8pp | 22.2%+2.1pp | 12.6%+3.3pp | 7.1%-1.8pp | -19.3%-0.7pp | 20.2%-0.4pp | 9.3%-2.8pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Crh Plc CRH | FY2025 | $37.4B | $3.8B | 10.0% | $59.4B | 58/100 |
| Vulcan Matrls VMC | FY2025 | $7.9B | $1.1B | 13.6% | $32.4B | 62/100 |
| Martin Mari Mat MLM | FY2025 | $6.2B | $1.1B | 18.5% | $35.7B | 65/100 |
| Cemex SAB de CV CX | FY2025 | $16.1B | $970.0M | 6.0% | $15.7B | 29/100 |
| James Hardie JHX | FY2026 | $4.8B | $104.0M | 2.1% | $16.8B | 54/100 |
| Eagle Matls Inc EXP | FY2026 | $2.3B | $423.8M | 18.4% | $5.7B | 71/100 |
Where Crh Plc Ranks
Frequently Asked Questions
What is Crh Plc's annual revenue?
Crh Plc (CRH) reported $37.4B in total revenue for fiscal year 2025. This represents a 5.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Crh Plc's revenue growing?
Crh Plc (CRH) revenue grew by 5.3% year-over-year, from $35.6B to $37.4B in fiscal year 2025.
Is Crh Plc profitable?
Yes, Crh Plc (CRH) reported a net income of $3.8B in fiscal year 2025, with a net profit margin of 10.0%.
What is Crh Plc's EBITDA?
Crh Plc (CRH) had EBITDA of $7.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Crh Plc have?
As of fiscal year 2025, Crh Plc (CRH) had $4.1B in cash and equivalents against $16.5B in long-term debt.
What is Crh Plc's gross margin?
Crh Plc (CRH) had a gross margin of 36.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Crh Plc's operating margin?
Crh Plc (CRH) had an operating margin of 14.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Crh Plc's net profit margin?
Crh Plc (CRH) had a net profit margin of 10.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Crh Plc pay dividends?
Yes, Crh Plc (CRH) paid $1.48 per share in dividends during fiscal year 2025.
What is Crh Plc's return on equity (ROE)?
Crh Plc (CRH) has a return on equity of 15.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Crh Plc's free cash flow?
Crh Plc (CRH) generated $2.9B in free cash flow during fiscal year 2025. This represents a 20.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Crh Plc's operating cash flow?
Crh Plc (CRH) generated $5.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Crh Plc's total assets?
Crh Plc (CRH) had $58.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Crh Plc's capital expenditures?
Crh Plc (CRH) invested $2.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Crh Plc's current ratio?
Crh Plc (CRH) had a current ratio of 1.74 as of fiscal year 2025, which is generally considered healthy.
What is Crh Plc's debt-to-equity ratio?
Crh Plc (CRH) had a debt-to-equity ratio of 0.69 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Crh Plc's return on assets (ROA)?
Crh Plc (CRH) had a return on assets of 6.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Crh Plc's P/E ratio?
Crh Plc (CRH) trades at 15.5x earnings, its market capitalization divided by net income of $3.8B net income, trailing 12 months to June 30, 2026. The market capitalization is $59.4B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Crh Plc's price-to-sales ratio?
Crh Plc (CRH) trades at 1.5x sales, its market capitalization divided by revenue of $38.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $59.4B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Crh Plc's Altman Z-Score?
Crh Plc (CRH) has an Altman Z-Score of 2.78, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Crh Plc's Piotroski F-Score?
Crh Plc (CRH) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Crh Plc's earnings high quality?
Crh Plc (CRH) has an earnings quality ratio of 1.50x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Crh Plc cover its interest payments?
Crh Plc (CRH) has an interest coverage ratio of 6.72x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Crh Plc?
Crh Plc (CRH) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.